Meta-analysis of clinical efficacy and safety of yangxuenao granules combined with cholinesterase inhibitors in the treatment of vascular cognitive impairment
Minerva Med
.
2023 Jun;114(3):399-401.
doi: 10.23736/S0026-4806.22.08339-2.
Epub 2022 Sep 30.
Authors
Chengxia Peng
1
,
Daoyou Zhou
2
Affiliations
1
Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
2
Department of Neurology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, China - zdy69@163.com.
PMID:
36178047
DOI:
10.23736/S0026-4806.22.08339-2
No abstract available
Publication types
Meta-Analysis
MeSH terms
Alzheimer Disease*
Cholinesterase Inhibitors / therapeutic use
Cognitive Dysfunction*
Humans
Treatment Outcome
Substances
Cholinesterase Inhibitors